AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 292: E1418-E1425, 2007. First published January 23, 2007; doi:10.1152/ajpendo.00335.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/E1418    most recent
00335.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egecioglu, E.
Right arrow Articles by Wickman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egecioglu, E.
Right arrow Articles by Wickman, A.

Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function

E. Egecioglu,1 I. J. Andersson,1 E. Bollano,2,3 V. Palsdottir,4 B. G. Gabrielsson,4 J. J. Kopchick,5 O. Skott,6 P. Bie,6 J. Isgaard,7 M. Bohlooly-Y,8 G. Bergström,1,7 and A. Wickman1

Departments of 1Physiology and 2Cardiology, 3Wallenberg Laboratory for Cardiovascular Research, 4Department of Metabolism and Cardiovascular Research, Sahlgrenska Academy, Göteborg University, Gothenberg, Sweden; 5Edison Biotechnology Institute and Department of Biomedical Sciences, Ohio University, Athens, Ohio; 6Department of Physiology and Pharmacology, Institute of Medical Biology, Syddansk University, Odense, Denmark; 7Department of Clinical Physiology, Sahlgrenska Academy, Göteborg University, Gothenberg, Sweden; and 8AstraZeneca R&D, Mölndal, Sweden

Submitted 11 July 2006 ; accepted in final form 12 January 2007

To study the role of the growth hormone receptor (GHR) in the development of cardiovascular structure and function, female GHR gene-disrupted or knockout (KO) and wild-type (WT) mice at age 18 wk were used. GHR KO mice had lower plasma renin levels (12 ± 2 vs. 20 ± 4 mGU/ml, P < 0.05) and increased aortic endothelial NO synthase (eNOS) expression (146%, P < 0.05) accompanied by a 25% reduction in systolic blood pressure (BP, 110 ± 4 vs. 147 ± 3 mmHg, P < 0.001) compared with WT mice. Aldosterone levels were unchanged, whereas the plasma potassium concentration was elevated by 14% (P < 0.05) in GHR KO. Relative left ventricular weight was 14% lower in GHR KO mice (P < 0.05), and cardiac dimensions as analyzed by echocardiography were similarly reduced. Myograph studies revealed a reduced maximum contractile response in the aorta to norepinephrine (NE) and K+ (P < 0.05), and aorta media thickness was decreased in GHR KO (P < 0.05). However, contractile force was normal in mesenteric arteries, whereas sensitivity to NE was increased (P < 0.05). Maximal acetylcholine-mediated dilatation was similar in WT and GHR KO mice, whereas the aorta of GHR KO mice showed an increased sensitivity to acetylcholine (P < 0.05). In conclusion, loss of GHR leads to low BP and decreased levels of renin in plasma as well as increase in aortic eNOS expression. Furthermore, GHR deficiency causes functional and morphological changes in both heart and vasculature that are beyond the observed alterations in body size. These data suggest an important role for an intact GH/IGF-I axis in the maintenance of a normal cardiovascular system.

cardiac structure; cardiac function; vascular structure; vascular function; endothelial nitric oxide synthase; growth hormone receptor-null mice


Address for reprint requests and other correspondence: E. Egecioglu, Dept. of Physiology, The Sahlgrenska Academy, Göteborg University, PO Box 434, SE-405 30 Gothenberg, Sweden (e-mail: emil.egecioglu{at}medic.gu.se)




This article has been cited by other articles:


Home page
 J Gerontol A Biol Sci Med SciHome page
M. O. Thorner
Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span
J Gerontol A Biol Sci Med Sci, October 1, 2009; 64A(10): 1039 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. Telgmann, C. Dordelmann, E. Brand, V. Nicaud, C. Hagedorn, H. Pavenstadt, F. Cambien, L. Tiret, M. Paul, and S.-M. Brand-Herrmann
Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation
FASEB J, May 1, 2009; 23(5): 1303 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. F. Giani, M. S. Bonkowski, M. C. Munoz, M. M. Masternak, D. Turyn, A. Bartke, and F. P. Dominici
Insulin Signaling Cascade in the Hearts of Long-Lived Growth Hormone Receptor Knockout Mice: Effects of Calorie Restriction
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2008; 63(8): 788 - 797.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.